The sociodemographic characteristics and dietary and blood plasma fatty acid profiles of elderly Saudi women with Alzheimer disease

Table 2 Fatty acid profile of food in control and AD* patients

Fatty acid from Food (g/day)	National Guard Health Affairs- King Abdulaziz Medical City, Riyadh (NGH)		Social Welfare Homes for the Elderly (SWH)
	Control	Alzheimer	Control	Alzheimer
LA (Linoleic acid; C18:2)	31.77 ± 2.902^Aa	25.21 ± 2.221^Bb	30.80 ± 3.0319^Aa	26.34 ± 2.0249^Bb
AA (Arachidonic acid; C20:4)	0.081 ± 0.006^Aab	0.067 ± 0.0015^Bb	0.077 ± 0.0022^Aab	0.089 ± 0.0060^Aa
ALA (α-linolenic acid; C18:3)	0.924 ± 0.0103^Aa	0.816 ± 0.0240^Aa	0.920 ± 0.0105^Aa	0.844 ± 0.0216^Aa
EPA (Eicosapentaenoic acid; C20:5)	0.050 ± 0.0051^Aab	0.023 ± 0.0017^Bb	0.071 ± 0.0075^Aa	0.052 ± 0.0046^Aab
DHA (Docosahexaenoic acid; C22:6)	0.012 ± 0.0005^Aa	0.007 ± 0.0005^Ba	0.013 ± 0.0006^Aa	0.013 ± 0.0014^Aa
Total ω-6	31.85 ± 2.908^Aa	25.27 ± 6.23^Bb	30.87 ± 3.0332^Aa	26.43 ± 2.0265^Bb
Total ω-3	0.986 ± 0.0117^Aa	0.846 ± 0.0260^Bb	1.002 ± 0.0126^Aa	0.909 ± 0.0253^Aab
ω-6/ ω-3	32.30 ± 2.279^Aa	29.86 ± 2.552^Aa	30.80 ± 3.0893^Aa	29.075 ± 2.0848^Aa

*AD-Alzheimer disease; Results are reported in mean ± standard deviation
^abDifferent superscripts denote a statistically significant difference between controls of two different places and between Alzheimer patients of two places
^ABDifferent superscripts denote a statistically significant difference between controls and Alzheimers patients of each place individually

ISSN: 1476-511X